NO-synthase inhibitors provide influence on protective effect of modified endotoxine diphosphoryl lipid A in a rat heart model of ischemic-reperfusion injury

Pharmazie. 2006 Jun;61(6):568-70.

Abstract

The present study was designed to assess whether a protective effect of the modified diphosphoryl lipid A (modLA) against myocardial ischemia-reperfusion injury (IRI) in rats can be related to the mechanism involving inducible nitric oxide synthase (iNOS). Pre-treatment with modLA significantly reduced the duration of both ventricular tachycardia (p < 0.01) and ventricular fibrillation (p < 0.001) compared to controls. Under these conditions the incidence of animal death was reduced (p < 0.05). The beneficial effect of modLA was markedly attenuated by the prior administration of selective iNOS inhibitor S-methylisothiourea (SMT). In this animal group, mortality was significantly increased (p < 0.01) partially in consequence of sustained ventricular arrhythmias. These results indicate that induction of iNOS can be responsible for cardioprotection of modLA.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cardiotonic Agents / pharmacology*
  • Enzyme Inhibitors / pharmacology*
  • In Vitro Techniques
  • Isothiuronium / analogs & derivatives
  • Isothiuronium / pharmacology
  • Lipid A / analogs & derivatives*
  • Lipid A / pharmacology
  • Male
  • Myocardial Reperfusion Injury / pathology
  • Myocardial Reperfusion Injury / prevention & control*
  • NG-Nitroarginine Methyl Ester / pharmacology
  • Nitric Oxide Synthase Type II / antagonists & inhibitors*
  • Rats
  • Rats, Wistar
  • Tachycardia / drug therapy
  • Tachycardia / physiopathology

Substances

  • Cardiotonic Agents
  • Enzyme Inhibitors
  • Lipid A
  • diphosphoryl lipid A
  • Isothiuronium
  • Nitric Oxide Synthase Type II
  • S-methylisothiopseudouronium
  • NG-Nitroarginine Methyl Ester